| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |